Gene Query: FGFR1OP2

Dataset Description Geneva Score
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 49.5
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 49.5
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 29.61
Tracking of dCas9-methyltransferase footprints 28.48
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 22.44
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 21.86
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 20.62
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 16.14
Human cell line and subcutaneous tumor 15.7
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 14.01
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 13.55
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 13.12
Global epigenomic reconfiguration during mammalian brain development 12.91
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 12.68
ETV7 and interferon response 12.68
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 12.24
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 12.09
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 11.92
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 11.64
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 11.64
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 11.62
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.33
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.33
MYCi361 regulates MYC target genes 11.25
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 11.06
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 11.06
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 10.22
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 10.14
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 9.88
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 9.79
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 9.61
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 9.59
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.58
Gene expression profile of human iPSC-derived nephron progenitor cells 9.56
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 9.42
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 9.26
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.2
Active translatome profiling with RiboLace in MCF7 cells 9.14
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 8.89
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 8.89
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.86
Transcriptional profiling of LS1034 cells treated with tepoxalin 8.78
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.71
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 8.66
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 8.6
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 8.54
Paxillin regulates genomic networks in prostate cancer [PC3] 8.5
Transcriptional profile in human S. haematobium infection 8.5
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 8.31
CROP-Seq in Primary Human T Cells 8.27
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 8.18
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.16
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 8.16
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 8.1
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.04
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.04
Regulation of protein translation during mitosis 8.01
The regulartory role of ZCCHC24 in splicing machinery 7.98
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.91
Global Mapping of Human RNA-RNA Interactions 7.86
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 7.86
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.85
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 7.82
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.65
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.65
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 7.63
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 7.53
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 7.49
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.33
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 7.31
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.26
Transciptomic profiling of human fetal lung samples 7.25
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 7.21
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 7.21
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 7.2
mRNA expression profile of Lymphocytes 7.12
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 7.12
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.09
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 7.07
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 7.06
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.04
3’ Uridylation Expands miRNA Target Repertoire 6.93
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 6.93
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 6.93
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.89
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 6.87
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.85
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.85
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.81
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 6.74
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 6.72
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 6.72
MAIT cell RNA sequencing 6.64
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 6.63
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.62
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.62
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.61
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.59
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 6.55
Rorc disruption in human FG pancreatic cancer cells 6.26
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.26
LncRNA expression profiling of ischemic stroke patients 6.18
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.1
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.04
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 5.95
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 5.94
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.92
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 5.91
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 5.91
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 5.9
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.86
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.85
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 5.82
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 5.82
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 5.82
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 5.79
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 5.78
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.77
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.76
SLAM-seq for K562 endogenous mRNA decay 5.76
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 5.73
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.69
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.67
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 5.63
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 5.63
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 5.62
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.5
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 5.5
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 5.42
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 5.42
Differentially expressed genes post knock down of lincDUSP26 5.41
Ribosomal footprinting of CN34-Parental and CN34-LM1a 5.35
U2AF1 mutations alter splice site recognition in hematological malignancies 5.34
Single-cell analysis of human kidney organoids 5.27
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 5.27
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 5.25
Transcriptome analysis of U87 cells upon LINC00152 knockdown 5.25
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 5.24
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.22
TT-Seq captures the human transient transcriptome 5.19
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 5.19
Trans-differentiation of human adult peripheral blood T cells into neurons 5.13
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.1
Ribosomal footprinting of MDA-Parental and MDA-LM2 5.1
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.09
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.09
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 5.08
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.08
RNA-Seq analysis of breast cancer cells after shikonin treatment 5.08
Primate transcript and protein expression levels evolve under compensatory selection pressures 5.01
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 5.01
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.0
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.99
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 4.98
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 4.98
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 4.97
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.96
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.96
Epigenomic landscape during organ formation in human early embryos 4.95
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.93
Short and Long RNA sequencing of human mature erythrocytes 4.93
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 4.92
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 4.92
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.89
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 4.89
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.86
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 4.86
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 4.86
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.83
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 4.82
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.8
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.79
RNA-seq analyses of human prostate cancer cells 4.78
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.78
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.72
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 4.72
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.71
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.71
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.65
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.65
SUV420H2 knockdown in PANC-1 4.64
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.63
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.61
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.59
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 4.58
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.57
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.56
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.56
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 4.54
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.46
Microglia innatly develop within cerebral organoids 4.45
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.44
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.43
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.43
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 4.38
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 4.35
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 4.32
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 4.31
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 4.3
UV_24h_GRO-Seq 4.24
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 4.23
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.21
MEIS1 regulates hematopoiesis in hPSCs 4.2
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 4.19
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 4.13
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.11
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.1
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.09
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.08
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.07
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.07
Effect of PRDM11 depletion in U2932 cells 4.07
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.07
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.05
RNA expression analysis upon JMJD1C depletion 4.05
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.05
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.01
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.0
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.0
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 3.97
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 3.94
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.93
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.93
Transcriptome profiling of 5 human adenocarcinoma cell lines 3.93
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.9
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 3.9
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.89
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 3.87
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.83
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.82
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 3.81
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.8
Transcriptome analysis of peripheral blood monocytes 3.79
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 3.78
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 3.77
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 3.77
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.77
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 3.74
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.72
Human Treg NaCl stimulation 3.7
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.69
RNA sequencing of primary human platelets and in vitro cell lines 3.68
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 3.64
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 3.64
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.64
HEK293 TFAM Knockout Expression Study 3.63
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 3.62
Endothelial gene expression analysis 3.61
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.61
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.59
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 3.59
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 3.58
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.57
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 3.57
Expression by CD133+ cells isolated from the adult human exocrine pancreas 3.55
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 3.54
Regulation of poly(A) tail and translation during the somatic cell cycle 3.52
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.5
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.49
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 3.48
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 3.41
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.38
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.38
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 3.36
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.35
Noncoding regions are the main source of targetable tumor-specific antigens 3.35
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 3.34
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.32
Transcriptome-wide response to synthetic chromatin protein PcTF 3.31
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 3.31
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 3.31
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.29
DRB/GRO-Seq -/+ UV 3.26
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 3.26
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 3.26
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.24
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.22
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.21
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 3.16
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.16
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 3.15
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 3.15
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 3.14
RNA sequencing analysis of selumetinib-resistant CRC cells lines 3.11
RNA-seq analysis of control and Myc-induced U2OS cells 3.1
Trascriptome of thyroid cancer-induced macrophages 3.06
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.05
Gene expression profiling of leukemia cells following asparagine depletion 3.0
Unique features and clinical importance of acute alloreactive immune responses 3.0
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.0
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.99
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.95
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.92
IMP3 regulated gene expression in breast cancer cells 2.92
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.9
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.9
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.88
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.85
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 2.81
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.78
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.74
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.74
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.74
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.7
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.69
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.67
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.67
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.67
The Genetic Landscape of Diamond-Blackfan Anemia 2.67
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.64
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 2.61
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.58
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.58
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.58
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.57
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.52
Single-Cell Genotyping of Transcriptomes 2.52
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.52
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.48
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.47
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 2.46
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.46
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.44
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.43
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.38
RNA sequencing of human mammary epithelial cells 2.37
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 2.27
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.27
RNA-seq in endometrial stromal tumors 2.26
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.24
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.23
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.2
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.2
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.16
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 2.16
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.16
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 2.14
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.13
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.1
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.09
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 2.09
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.05
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.0
Global response to chemotherapy-induced apoptosis 1.97
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.96
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.94
RNAseq in Alzheimer's Disease patients 1.94
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.9
Transcriptional landscape changes during human embryonic stem cell derivation 1.89
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.88
The transcriptome of Kawasaki Disease arteritis 1.88
mRNA recovered upon RNF219 IP. [RNA-IP] 1.85
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.84
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.84
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.83
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.83
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.82
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.81
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.77
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.76
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.73
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.71
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.71
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.64
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.64
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.64
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.62
Oncogenic roles of ARID5B in T-ALL 1.62
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.61
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.61
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.6
Mapping interactions for the TNIP2 hub protein 1.59
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.58
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.56
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.54
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.52
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.52
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.51
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.49
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.49
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.49
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.48
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.47
Alteration of the microRNA network during the progression of Alzheimer’s disease 1.45
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.44
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.4
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.38
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.37
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.35
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.35
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.32
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.32
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.32
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.31
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.3
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.28
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 1.26
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.24
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.19
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.18
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.16
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.16
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.15
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.15
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.15
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.12
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.12
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.12
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.11
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.09
Human Tfh cell RNA bulk sequencing 1.06
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.05
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.04
Gene expression changes due to PARP knockdown in human cells 1.01
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.01
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.99
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.98
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.94
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.94
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.93
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.93
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.87
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 0.86
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.86
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.85
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.85
RNA-seq of primary patient AML samples 0.83
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.82
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.82
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.81
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.81
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.8
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.8
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.78
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.75
Modulation of nonsense-mediated decay by rapamycin 0.72
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.71
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.71
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.7
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.69
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.67
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.67
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.66
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.63
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.62
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.57
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.57
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.52
RNA-Seq in PWS iPSC-derived neurons 0.51
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.51
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.5
Metastasis in triple-negative breast cancer 0.48
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.48
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.46
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.46
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.42
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.42
Human Treg IFNg/IL-10 subpopulations 0.4
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.4
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.39
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 0.39
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.38
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.36
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.35
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.35
siRNA-mediated knockdown 0.35
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.33
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.33
Function and hormonal regulation of GATA3 in human first trimester placentation 0.33
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.32
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.31
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.31
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.31
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.3
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.29
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.28
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.27
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.25
The DNA methylation landscape of human melanoma 0.22
The DNA methylation landscape of human melanoma [RNA-Seq] 0.22
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.21
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.19
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.17
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.16
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.14
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.14
Role of cervicovaginal microbiota in genital inflammation 0.14
Impact on erythroid progenitor type on erythroid differntiation 0.13
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.13
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.11
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.11
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.1
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.06
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.04
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.04
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.04
Aging-associated patterns in the expression of human endogenous retroviruses 0.03
Transcriptome-wide modulation of splicing by the exon junction complex 0.03
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation